| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |